Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers
Not Applicable
- Conditions
- BRCA1/2 Mutation Carriers
- Registration Number
- JPRN-UMIN000026509
- Lead Sponsor
- Cancer Institute Hospital department of clinical genetic oncology, breast center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The individuals who do not wish to participate to this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We investigated the distinct roles of mammography, ultrasonography, MRI, and CBE for the detection of breast cancer in women with BRCA1/2 mutations. The medical records of participants who were confirmed to have BRCA1/2 mutations during genetic counseling between January 1, 2000 and October 31, 2016 were reviewed.
- Secondary Outcome Measures
Name Time Method